Takeda Takes Stake, Inks Deal With Newly Launched Izana Bioscience Post author:Sam Post published:December 13, 2017 Post category:BioPharma As part of the licence agreement, Takeda has taken a strategic equity stake in Izana. Source: BioSpace You Might Also Like IMRALDI, Biogen???s Adalimumab Biosimilar Referencing Humira, Is Approved In The European Union August 24, 2017 Creative Bioarray Release: New Products of FISH Have Been Released In Company January 19, 2017 Jounce Names Ex-Ariad's Top Dealmaker as Its New CBO August 15, 2017
IMRALDI, Biogen???s Adalimumab Biosimilar Referencing Humira, Is Approved In The European Union August 24, 2017
